A randomized phase II Trial evaluating the endocrine activity and efficacy of neoadjuvant degarelix versus triptorelin in premenopausal patients receiving letrozole for Primary endocrine responsive breast cancer

Study Chair
Dr. Silvia Dellapasqua, Milan, Italy
Dr. Marco Colleoni, Milan, Italy

Statistician
Dr. P. Kathryn Gray

Lead Trial Coordinator
Holly Shaw

Trial Monitors
Giuseppe Achille, Daniela Celotto, Carmen Comune

IBCSG Coordinating Center, Bern, Switzerland
Phone: +41 31 511 94 00
Fax: +41 31 511 94 01
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 833 3990
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Date of Activation
March 28, 2013

Targeted Accrual
50 patients

Final Accrual
51 patients

Date of enrollment closure
January 10, 2017

International Breast
Cancer Study Group

Effingerstrasse 40
3008 Bern, Switzerland

Contact
Phone: +41 31 511 94 00
E-mail: ibcsgcc@ibcsg.org

Member Login